Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dow

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Blood|March 15, 1991
CD8/CD57 lymphocytosis in common variable immunodeficiencyN Dow
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|December 25, 2003
Missing cyclistsJ D Langley, N Dow, S Stephenson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
How many children remain fracture-free during growth? a longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development StudyI E Jones, S M Williams, N Dow, et al.
Journal of Veterinary Internal Medicine|December 28, 2017
Effect of Heat-treatment on Accuracy of Infrared Spectroscopy and Digital and Optical Brix Refractometers for Measuring Immunoglobulin G Concentration in Bovine ColostrumI Elsohaby, J T McClure, N Dow, et al.
Human Pathology|March 1, 1984
Primary omental leiomyosarcoma masquerading as hemorrhagic ascitesA Y Dixon, J S Reed, N Dow, et al.
Cancer|January 15, 1990
Hairy cell leukemia in two siblings. A human leukocyte antigen-linked disease?F T Ward, J Baker, J Krishnan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2019
Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicitiesCatherine E Renna, Elizabeth N Dow, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 7, 2020
PARP-inhibitor potpourri: A comparative review of class safety, efficacy, and costEmily R Hennes, Elizabeth N Dow-Hillgartner, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 21, 2020
Hypertension and QT interval prolongation associated with targeted systemic cancer therapiesOlivia G Fahey, Jennifer K Piccolo, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 16, 2020
Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practiceDaniel J Przybylski, Elizabeth N Dow-Hillgartner, Michael P Reed, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Blood|March 15, 1991
CD8/CD57 lymphocytosis in common variable immunodeficiencyN Dow
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|December 25, 2003
Missing cyclistsJ D Langley, N Dow, S Stephenson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
How many children remain fracture-free during growth? a longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development StudyI E Jones, S M Williams, N Dow, et al.
Journal of Veterinary Internal Medicine|December 28, 2017
Effect of Heat-treatment on Accuracy of Infrared Spectroscopy and Digital and Optical Brix Refractometers for Measuring Immunoglobulin G Concentration in Bovine ColostrumI Elsohaby, J T McClure, N Dow, et al.
Human Pathology|March 1, 1984
Primary omental leiomyosarcoma masquerading as hemorrhagic ascitesA Y Dixon, J S Reed, N Dow, et al.
Cancer|January 15, 1990
Hairy cell leukemia in two siblings. A human leukocyte antigen-linked disease?F T Ward, J Baker, J Krishnan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2019
Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicitiesCatherine E Renna, Elizabeth N Dow, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 7, 2020
PARP-inhibitor potpourri: A comparative review of class safety, efficacy, and costEmily R Hennes, Elizabeth N Dow-Hillgartner, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 21, 2020
Hypertension and QT interval prolongation associated with targeted systemic cancer therapiesOlivia G Fahey, Jennifer K Piccolo, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 16, 2020
Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practiceDaniel J Przybylski, Elizabeth N Dow-Hillgartner, Michael P Reed, et al.
Pageof 2